drug

vonsetamig

1 story · latest Aug 21, 2026

Status: Investigational
Code: REGN5459
Trials: 3 registered trials in coverage

Relationships

Developed by Regeneron Pharmaceuticals

Also known as

noninterventional

Timeline

Regeneron lists vonsetamig as available under compassionate use program

Aug 21Trial updateRegeneron Pharmaceuticals vonsetamig

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.